Joseph Jankovic, M.D.

Click on the Expand plus sign sign for the listing of news and events by year. Then click on the link for details or press release.

Vial welcomes new addition, Dr. Joseph Jankovic of Baylor College of Medicine to their Neurology CRO Advisory Board Nov. 9, 2022: Vial welcomes Dr. Joseph Jankovic as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Jankovic is a…
Tardive dyskinesia drug safe, effective for Huntington's chorea April 19, 2022: Valbenazine is effective in improving symptoms of chorea for patients with Huntington's disease, without any increase in suicidal ideation or suicidal behavior, phase 3 trial results show.
Controversial Alzheimer's drug approval could affect other diseases June 29, 2021: Aducanumab's fast-tracking has researchers both worried and hopeful about the future of drugs for neurodegenerative diseases such as Huntington's and Parkinson's.
Positive topline results for new cervical dystonia treatment Oct. 14, 2020: DaxibotulinumtoxinA for treatment of cervical dystonia met the primary and secondary endpoints in the ASPEN-1 phase 3 trial, Revance Therapeutics reports.
Dr. Chintan Shah chosen for movement disorders fellowship Oct. 22, 2019: Dr. Chintan Shah, medical resident at Baylor College of Medicine, has been selected to join The Michael J. Fox Foundation's Edmond J. Safra Fellowship in Movement Disorders class of 2022.
New guidelines outline methods to manage tic disorders May 6, 2019: New guidelines by the American Academy of Neurology outline effective ways to treat the symptoms of tics for those living with Tourette syndrome that range from new therapies to holistic care.
Delays in Parkinson's Treatment Due to Fear of Side Effects a Serious Problem, Neurologist Says April 4, 2019: Fear of side effects of Parkinson's treatments, "Levodopa Phobia," leads patients and their doctors to delay use of needed therapies, a neurologist says.
Baylor's Parkinson's Center selected for Michael J. Fox Foundation fellowship April 3, 2019: The Parkinson's Disease Center and Movement Disorders Clinic at Baylor College of Medicine has been chosen by the Michael J. Fox Foundation as one of five academic centers to receive the Edmond J. Safra Fellowship in Movement Disorders.
Jankovic honored for career achievement Jan. 4, 2019: Jankovic selected by the International Neurotoxin Association to receive its Lifetime Achievement Award.
Small Vessel Disease in Parkinson's Can Lead to Worsening Motor Impairment Dec. 6, 2018: Researchers found that small vessel disease was associated with worsening motor impairment in Parkinson's disease.
Former President George H.W. Bush Dies Dec. 1, 2018: George Herbert Walker Bush, the nation's oldest living former president, has died at the age of 94.
Electrophysiological signals identify Parkinson's subtypes Aug. 22, 2018: Researchers have now found neural correlates of two main Parkinson's disease phenotypes that could lead to more precise or personalized deep brain stimulation treatments.
Weighing the Risks of Deep Brain Stimulation July 9, 2018: DBS has been known to generate other movement-related disorders such as dyskinesias, blepharospasm, and hypokinesia.
Weighing the risks of deep brain stimulation July 9, 2018: DBS has been known to generate other movement-related disorders such as dyskinesias, blepharospasm, and hypokinesia.
Alpha-synuclein antibody shows promise for Parkinson's disease treatment July 3, 2018: Multiple intravenous infusions of PRX002, a humanized monoclonal antibody targeting neurotoxic forms of aggregated alpha-synuclein, was safe and well tolerated in patients with mild to moderate Parkinson's disease…
'Promising' preliminary results for antibody in Parkinson's June 27, 2018: An early clinical trial of a monoclonal antibody targeting what could be an underlying cause of Parkinson's disease has shown some encouraging results, researchers say.
α-synuclein antibody appears safe, reaches brain June 22, 2018: In the June 18 JAMA Neurology, researchers led by Joseph Jankovic at Baylor College of Medicine, Houston, published results from the Phase 1b safety and tolerability trial of Roche and Prothena's anti-α-synuclein antibody PRX002/RG7935.
Biologic Drug for Parkinson's Disease? June 18, 2018: In phase Ib trial, investigational mAb targets aggregated alpha-synuclein
Nuplazid's risks in treating Parkinson's psychosis don't appear exceptionally high, experts say June 11, 2018: Experts appear to take a more questioning view of the risks of Nuplazid, Acadia's approved treatment for psychosis in Parkinson's disease, than that aired by general media.
The ultimate race: Powering through Parkinson's disease April 11, 2018: Allison Toepperwein reflects on her journey with Parkinson's disease and why she appreciates every moment in life.
Grind your teeth at night? Botox may help Jan. 18, 2018: If you're one of the millions of people who grind and clench their teeth during sleep, an injection of Botox might be the answer, a small study suggests.
Six Reasons Why Your Hands Are Shaking Dec. 27, 2017: Everything from a hard workout to underlying disease could explain your shakes.
Defects in cell's "waste disposal system" linked to Parkinson's Nov. 13, 2017: An international study has shed new light on the genetic factors associated with Parkinson's disease.
Pearls From: Joseph Jankovic, MD May 30, 2017: Targeting alpha-synuclein in Parkinson's
Higher death risk with all synucleinopathies May 15, 2017: Lowest with Parkinson's disease, highest for multiple system atrophy with parkinsonism
α-Synuclein Antibodies Enter Phase 2, Sans Biomarker May 6, 2017: In the search for ways to slow down the progression of Parkinson's disease, researchers currently have α-synuclein in their crosshairs. A handful of approaches are in development, and immunotherapy strategies are now advancing through clinical trials.
AAN Debate: Neurologists Divided on Amyloid as Alzheimer Target May 1, 2017: Many attendees say the pathway is still worth exploring.
Jankovic interviewed at the American Academy of Neurology annual meeting April 25, 2017: Updates in Hypokinetic Movement Disorders
Jankovic interviewed at the American Academy of Neurology annual meeting April 25, 2017: Parkinson's Disease: Addressing Older Generational Treatments
Jankovic interviewed at the American Academy of Neurology annual meeting April 25, 2017: Botulinum Neurotoxin (BoNT): A Treatment for Neurologic and Non-Neurologic Disorders
Jankovic interviewed at the American Academy of Neurology annual meeting April 25, 2017: Botulinum Neurotoxin (BoNT): The Importance of Being a Skilled Clinician for Better Outcomes
Jankovic interviewed at the American Academy of Neurology annual meeting April 25, 2017: Updates in Hyperkinetic Movement Disorders: Current and Emerging Therapies
Jankovic interviewed at the American Academy of Neurology annual meeting April 25, 2017: Current updates in Parkinson's Disease and botulinum neurotoxin
A look at the esteemed career of Dr. Joseph Jankovic April 5, 2017: Forty years after joining Baylor College of Medicine, the work of Dr. Joseph Jankovic isn't slowing. As founder and director of the Parkinson's Disease Center and Movement Disorder Clinic, his work…
Positive Phase 1 Parkinson's Trial Results of New Therapy Reported by Prothena April 4, 2017: Read about Prothena's positive results from a Phase 1b clinical trial investigating a new antibody therapy for the treatment of Parkinson's disease.
Prothena pushes Roche-partnered Parkinson's drug into phase 2 after initial trial success April 3, 2017: Protein immunotherapy specialist Prothena is celebrating some positive early-stage data from a Roche-partnered program that aims to find a disease-modifying therapy for Parkinson's disease.
Jankovic received the Lifetime Achievement Award from the Texas Neurological Society March 23, 2017: Watch Dr. Jankovic's acceptance of this award.
An old drug gets a new price to fight a rare disease: $89,000 a year Feb. 10, 2017: A rare disease drug that has been used for years got FDA approval — and a new price.
Texas Tourette Symposium — What Makes Them Tic? Jan. 18, 2017: Jimenez-Shahed and Strutt co-direct an educational program that reviews the latest diagnostic and treatment options for Tourette syndrome (TS) and associated co-morbidities, updates research into TS genetics and pathophysiology, and provides information about helping individuals with TS and their families navigate the educational system.
Best of the best in care: Meet Houston's Top Doctors 2016 Oct. 21, 2016: Excellence in health care is a way of life in Houston. The MedCity section has looked to a list of America's Top Doctors, compiled by industry specialist Castle Connolly, to identify America's Top Doctors located right here in the Houston area. They exemplify excellence in Houston medicine.
The 10^th Annual Johns Hopkins Dystonia & Spasticity Practicum and Update Sept. 14, 2016: Jankovic and Jimenez-Shahed are invited faculty to the interactive CME activity.
New gene linked to Parkinson's disease June 17, 2016: Researchers recently added to the list of Parkinson's-associated genes when they identified mutations on TMEM230 linked to the disease. Discovery of this gene provides a new potential therapeutic target for PD treatment.
Are we getting closer to a cure for Parkinson's? June 7, 2016: Doctors at Baylor College of Medicine and Northwestern University recently discovered a gene that is not only linked to the disease but may explain how it causes the brain to go haywire.
Gene TMEM230 suggests novel mechanism for Parkinson's disease June 6, 2016: The discovery of a new gene, TMEM230, illuminates a possible mechanism to explain Parkinson's disease.
Exercise may slow symptoms of Parkinson's disease April 21, 2016: Experts at Baylor College of Medicine say that for some, regular exercise could slow the progression of Parkinson's disease.
Tourette Association of America designates the Parkinson's Disease Center and Movement Disorders Clinic as a Center of Excellence Oct. 13, 2015: Baylor is among 10 premier healthcare facilities, research centers and academic institutions located across the U.S. to be awarded up to $50,000 per year for three years in an effort to improve or build high-level care for individuals living with Tourette and tic disorders.
Celebrating 25 Years in Aspen - Parkinson Disease & Movement Disorders Course Sept. 16, 2015: The Comprehensive Review of Movement Disorders for the Clinical Practitioner held annually in Aspen, Colorado has just celebrated its 25th anniversary!
Parkinson's Disease and Other Movement Disorders: A Practical Approach Aug. 28, 2015: BCM Neurology faculty invited to speak at the Parkinson's Disease and Other Movement Disorders: A Practical Approach course, sponsored by the International Parkinson and Movement Disorder Society, on Oct. 17.
Jankovic to lead neurotoxin association May 29, 2015: Dr. Joseph Jankovic, professor of neurology and Distinguished Chair in Movement Disorders, was elected president of the International Neurotoxin Association…
25^th Annual Course: A Comprehensive Review of Movement Disorders for the Clinical Practitioner May 26, 2015: Course and registration information for the 25th annual course: A Comprehensive Review of Movement Disorders for the Clinical Practitioner
Author of "Healing Art - Don't Let Parkinson's Disease Ruin Your Day" visits the new Neurology Clinic May 13, 2015: Robert Flatt, a world renown photographer who donated some of his extraordinary photographs to the Department of Neurology Clinic…
Book Release – Parkinson's Disease and Movement Disorders, 6^th Edition April 24, 2015: Trusted as the leading text in the field, Parkinson's Disease and Movement Disorders, 6^th Edition, brings you fully up to date with new developments in this rapidly-changing subspecialty.
Book Release – Movement Disorders in Childhood, 2nd Edition April 10, 2015: Movement Disorders in Childhood, Second Edition provides the most up-to-date information diseases and disorders affecting motor control, an important area of specialization within child neurology.
Book Release – Movement Disorders, an Issue of Neurologic Clinics (The Clinics: Radiology) Dec. 25, 2014: The daily life impact of movement disorders on people affected ranges from the inconvenient to major quality of life issues, depending upon the disorder and its progression.
Auspex announces positive topline results from registration trial of SD-809 for chorea associated with Huntington's disease Dec. 16, 2014: Auspex Pharmaceuticals, Inc., a biopharmaceutical company dedicated to developing innovative medicines for people with movement disorders and other rare diseases, today announced positive topline efficacy and safety results from its Phase 3 registration trial evaluating SD-809 for the treatment of chorea associated with Huntington's disease (HD), called First-HD.
2014 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2014: November 19, 2014, has been designated as National Philanthropy Day. I would like to celebrate this special day by thanking you for your generous support of our Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC).
Baylor College of Medicine, Texas A&M designated as Center of Excellence by national Tourette Syndrome Association Sept. 30, 2014: Baylor, Texas A&M jointly named one of Tourette Syndrome Association Centers of Excellence to improve care for people living with the disorder.
Psyadon announces the opening of a new clinical trial of ecopipam for the treatment of Tourette's syndrome in children ages 7-17 May 28, 2014: Psyadon Pharmaceuticals announces the opening of a Phase 2b trial of its selective dopamine D1 receptor antagonist ecopipam for the treatment of child…
Jankovic awarded Master Clinician Lifetime Achievement May 13, 2014: The award recognizes full professors at the College who have made extraordinary contributions to patient care and clinical programs throughout their careers at BCM.
Astronaut's space secret revealed on big screen April 15, 2014: An accomplished astronaut flew three shuttle missions and logged more than 12 hours of spacewalk. Yet for 17 years, Rich Clifford, a handful of NASA officials and a Houston doctor were guarding a secret that made his triumphs all the more impressive.
Book Release – Movement Disorders in Neurologic and Systemic Disease April 7, 2014: Movement disorders - ranging from parkinsonism to a variety of hyperkinetic disorders, such as tremors, dystonic, chorea and myoclonus - can be the presenting or a prominent clinical feature in a broad spectrum of systemic conditions such as endocrine and metabolic disorders, autoimmune diseases, infections, intoxications, tumors and pareneoplastic syndromes, stroke and multiple sclerosis.
Can sense of smell determine if you'll get Parkinson's disease? Dec. 24, 2013: A study is underway to help determine if your sense of smell could determine your risk for developing Parkinson's disease years before you may even be affected by it.
2013 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2013: Each year I look forward to preparing this brief report of our clinical, research and educational activities because it gives me an opportunity to highlight some of the accomplishments of the Parkinson's Disease Center and Movement Disorders Clinic at Baylor College of Medicine during the past year and to express my gratitude to my patients, friends and colleagues for their continued support.
Book Release – Clinical Insights: Parkinson's Disease: Diagnosis, Motor Symptoms and Non-motor Features Aug. 27, 2013: With the increased recognition of the prodromal, premotor, and non-motor features of Parkinson's disease (PD), as well as the expanding knowledge concerning the clinical heterogeneity of PD, an overlap with other parkinsonian disorders and growing appreciation of genetic etiologies, there is a need to re-define PD, taking into account clinical, syndromic, etiologic and pathogenic aspects of parkinsonism.
BCM Parkinson's disease study seeks to discover new biomarkers; needs participants without the illness June 10, 2013: The Texas-based Parkinson Disease Center and Movement Disorder Clinic at Baylor College of Medicine will be helping researchers to understand the risk factors and causes of Parkinson's disease by participating in the Parkinson's Progression Markers Initiative's (PPMI) study.
Parkinson's disease study focuses on risk factors June 7, 2013: The Parkinson Disease Center and Movement Disorder Clinic at Baylor College of Medicine will participate in a new study to help researchers better understand potential risk factors for Parkinson's disease.
Former President George H.W. Bush hospitalized in Houston Nov. 29, 2012: Dr. Jankovic says President Bush has a milder form of Parkinson's, but it can still cause muscle stiffness in the chest that can make it harder to overcome respiratory illnesses.
2012 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2012: It is my pleasure to briefly summarize the activities of the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC) over the past year. When I founded the PDCMDC over 35 years ago I could only dream about the international acclaim that it now receives for its accomplishments in clinical care, research and education.
UCB's Neupro now available in U.S. pharmacies July 16, 2012: UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Jankovic's work to be featured at neurology meeting April 20, 2012: Dr. Joseph Jankovic, professor of neurology and director of the Parkinson Disease Center and Movement Disorder Clinic at Baylor College of Medicine, will have a busy week ahead at the American Academy of Neurology 64th Annual Meeting.
Book Release – Bradley's Neurology in Clinical Practice, 6^th Edition. Volume 1 - Principals of Diagnosis and Management April 12, 2012: Neurology in Clinical Practice brings you the most current clinical neurology through a comprehensive text, detailed color images, and video demonstrations. Drs. Daroff, Fenichel, Jankovic and Mazziotta, along with more than 150 expert contributors, present coverage of interventional neuroradiology, neurointensive care, prion diseases and their diagnoses, neurogenetics, and many other new developments.
Book Release – Bradley's Neurology in Clinical Practice, 6^th Edition. Volume 2 - Neurological Disorders April 12, 2012: Neurology in Clinical Practice brings you the most current clinical neurology through a comprehensive text, detailed color images, and video demonstrations. Drs. Daroff, Fenichel, Jankovic and Mazziotta, along with more than 150 expert contributors, present coverage of interventional neuroradiology, neurointensive care, prion diseases and their diagnoses, neurogenetics, and many other new developments.
Book Release – Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment March 7, 2012: Hyperkinetic movement disorders comprise a range of diseases characterized by unwanted and uncontrollable, or poorly controllable, involuntary movements. The phenomenology of these disorders is quite variable encompassing chorea, tremor, dystonia, myoclonus, tics, other dyskinesias, jerks and shakes.
Book Release – Neurological Clinical Examination: A Concise Guide, 3rd Edition Feb. 24, 2012: Neurological clinical examination: A concise guide and extensive video library provide a practical guide to the clinical neurological examination, an essential tool in the diagnosis of common and unusual neurological conditions encountered in the outpatient clinic and hospital ward.
Book Release – Psychogenic Movement Disorders and Other Conversion Disorders Jan. 16, 2012: This volume gives all of the available, up-to-date information on when to think about conversion in movement disorders, how to make a diagnosis, how to use the laboratory to support a clinical diagnosis and how to develop a therapeutic plan.
Okla. Couple come to Texas to help fight Parkinson's Oct. 10, 2011: An Oklahoma couple drive to Houston every few months to be a part of a landmark study on Parkinson's disease.
2011 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2011: The primary goal of this annual report is to provide a brief overview of the various activities at the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC). Consistent with our mission, the PDCMDC has continued to be engaged in a large number of clinical, research, educational and other academic activities.
Book Release – Principles and Practice of Movement Disorders: Expert Consult, 2^nd Edition Aug. 25, 2011: Principles and Practice of Movement Disorders provides the complete, expert guidance you need to diagnose and manage these challenging conditions.
Parkinson's disease as a punch line: Michael J. Fox on 'Curb Your Enthusiasm' May 19, 2011: Michael J. Fox will play himself in this season of 'Curb Your Enthusiasm' while he plays off his symptoms of Parkinson's disease.
A secret in space: NASA astronaut flew on Atlantis two years after Parkinson's diagnosis April 29, 2011: It's been 15 years since former astronaut Rich Clifford boarded the shuttle Atlantis with a secret — a secret he's now willing to share. Two years before his mission, Clifford was diagnosed with Parkinson's disease.
Man says Parkinson's drug made him addicted to gambling and gay sex Feb. 2, 2011: A 51-year-old man is suing the British pharmaceutical company GlaxoSmithKline, claiming Requip, the drug he took to treat his Parkinson's symptoms, turned him into a gambling and gay sex addict.
Book Release – Movement Disorders in Childhood: Expert Consult Dec. 15, 2010: Experts in the field, Drs. Singer, Mink, Gilbert, and Jankovic, fill the gap in the market by offering the only comprehensive text devoted solely to the diagnoses and treatment of all pediatric movement disorders.
Michael J. Fox: Volunteers help make Parkinson's research possible Dec. 12, 2010: I'm an advocate for Parkinson's disease research, in part because I have been living with the disease for close to 20 years - but also because the foundation I started in 2000 is convinced that we're closer than ever to developing Parkinson's treatments that far exceed what's available to patients today.
Botulinum Toxin Workshop Dec. 11, 2010: BCM Neurology faculty help organized the 4th annual Johns Hopkins Dystonia and Spasticity Practicum at the Marriott West Loop, Houston.
2010 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2010: Each year I try to provide a brief overview of the various activities at the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC). Since my last annual report, the PDCMDC has been engaged in a large number of clinical, research, educational and other academic activities consistent with our missions.
Baylor joins Parkinson's Progression Markers Initiative as official site Sept. 28, 2010: Enrollment open for Parkinson's disease program at BCM.
Potential role for histamine identified in Tourette's syndrome May 6, 2010: Researchers have uncovered a genetic defect in the histidine decarboxylase gene that may underlie Tourette's syndrome in a 2-generation pedigree.
Jankovic named 2010 Distinguished Faculty Award recipient April 6, 2010: Dr. Jankovic receives the 2010 Distinguished Faculty Award from the Baylor College of Medicine Alumni Association.
Jankovic gives invited "Great Teacher" lecture at NIH Dec. 9, 2009: Dr. Jankovic was selected by the National Institutes of Health as the "Great Teacher" and presented a special NIH Clinical Center Grand Rounds on "Treatment of Parkinson's Disease".
2009 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2009: I am pleased to highlight some of the accomplishments we have achieved at the PDCMDC during the past year and progress we have made since my last report.
Jankovic profiled in the Lancet Neurology journal Sept. 15, 2009: Joseph Jankovic is a man of many passions, the chief of which is a keen interest in movement disorders. Over the course of a career spanning more than 30 years…
Book Release – Botulinum Toxin: Therapeutic Clinical Practice and Science, Expert Consult Feb. 23, 2009: The new, therapeutically-focused Botulinum Toxin presents comprehensive, cross-disciplinary guidance on current practices, covering more than 100 non-cosmetic conditions that occur in neurology, physical medicine and rehabilitation, pain medicine, ophthalmology, gastroenterology, urology, orthopedics, and surgery.
First drug for Huntington's disease Dec. 23, 2008: The first effective treatment for the symptoms of Huntington's disease has been approved by the U.S. Food and Drug Administration. The drug won approval after a study by Baylor College of Medicine and the Huntington Study Group, an international group of physician scientists, showed the drug's effectiveness.
Doctor spent decades getting tetrabenazine to market Oct. 28, 2008: Baylor College of Medicine neurologist Joseph Jankovic took more than two decades to interest a U.S. company in bringing the Huntington's disease drug to market, a goal finally achieved.
Jankovic recognized for Huntington's disease research Oct. 20, 2008: Joseph Jankovic, M.D., professor of neurology and director of the Parkinson Disease Center and Movement Disorder Clinic, has been awarded the Guthrie Family Humanitarian Award from the Huntington's Disease Society of America for his leadership in research and patient care related to the disease.
2008 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2008: Each year I try to provide a snapshot of the various activities at the Parkinson Disease Center and Movement Disorders Clinic at Baylor College of Medicine. According to the 2008 U.S. News World Report, BCM remains among the top 10 medical schools in the nation…
First drug to treat Huntington's disease approved by FDA Aug. 26, 2008: The first effective treatment for the symptoms of Huntington's disease has now been approved by the U.S. Food and Drug Administration after study results by the Huntington Study Group and Baylor College of Medicine in Houston showed the drug's effectiveness.
FDA approves first drug for treatment of chorea in Huntington's disease Aug. 15, 2008: Research conducted by Dr. Jankovic was instrumental in getting tetrabenazine FDA-approved for the treatment of chorea in people with Huntington's disease.
Jankovic named distinguished chair in movement disorders at Baylor College of Medicine Jan. 23, 2008: The Baylor College of Medicine Board of Trustees has named Dr. Joseph Jankovic as distinguished chair in movement disorders.
Current Neurology 2007 Nov. 9, 2007: Previous program participants have requested and supported the need for a comprehensive review and update in selected areas for the practicing neurologist with a focus on movement disorders. As clinical neurology continues to evolve with the explosion of discoveries in the neurosciences, the neurology faculty and the CME planning committee strongly concur with the need to such a conference.
2007 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2007: This is the season when I annually reflect on our achievements during the past year and the challenges we are facing in the future. I am pleased to highlight some of the accomplishments and progress we have made over the past year.
Skin patch spells relief for Parkinson's patients Sept. 15, 2007: A new skin-based method—a patch—to administer medicine to Parkinson's disease patients could deliver big benefits.
Parkinson's skin patch 'a big plus' July 5, 2007: James Papadakis was two years into his battle with Parkinson's disease and his symptoms had taken a turn for the worse when his Baylor College of Medicine doctor suggested an experimental new skin patch back in 2002.
Jankovic recognized for movement disorders research March 15, 2007: Joseph Jankovic, M.D., Baylor College of Medicine professor of neurology and director of the Parkinson's Disease Center and Movement Disorders Clinic, has been selected as the 2007 recipient of the American Academy of Neurology Movement Disorders Research Award.
2006 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2006: This Thanksgiving season I again wish to share with you my pride of the accomplishments of our team and to update you on the clinical, research and educational activities of the Parkinson Disease Center and Movement Disorders Clinic at Baylor College of Medicine.
Book Release – Parkinson's Disease and Movement Disorders, 5^th Edition Sept. 29, 2006: Written by an international group of renowned experts, the Fifth Edition of this premier reference provides comprehensive, current information on the genetics, pathophysiology, diagnosis, medical and surgical treatment, and behavioral and psychologic concomitants of all common and uncommon movement disorders.
Parkinson's patients stomach new drug better than conventional meds June 12, 2006: Several studies conducted at Baylor College of Medicine (BCM) in Houston show that a new kind of orally disintegrating tablets provides improved symptom relief for patients with Parkinson's disease.
Hurricane damage poses no 'hazard' to record-breaking golf benefit April 15, 2006: Former Mayor Maury Meyers of Beaumont, Texas lays claim to a respectable 11 handicap on the golf course – not bad for most amateurs; exceptional for a patient with Parkinson's Disease.
Understanding the brain and movement April 15, 2006: Joseph Jankovic, M.D., professor of neurology at Baylor College of Medicine, is internationally regarded for his unwavering dedication to his patients and his extraordinary productivity in research.
First Colony man overcomes Tourette's Syndrome March 12, 2006: First Colony resident Sean A. Wolfson was often asked to sit in the back of a school classroom because of Tourette's Syndrome.
Hurricane Rita poses no threat to Parkinson's golf tournament's record-breaking success Jan. 15, 2006: Undaunted by Hurricane Rita, former Beaumont Mayor Maury Meyers and fellow organizers rescheduled the Dr. Sol and Miriam Rogers Golf Tournament and succeeded in raising $62,000 for Parkinson's disease research…
Physical activity keeps Parkinson's at bay Jan. 10, 2006: "There's no doubt that people who have a positive attitude and exercise generally cope with the disease much better than those who don't," said Dr. Joseph Jankovic, professor of neurology and director of the Parkinson's center at Baylor College of Medicine.
2005 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2005: Each year I look forward to the Thanksgiving season as this offers an opportunity to express my gratitude to my friends and colleagues for their continued support and to reflect on the accomplishments and goals of the Parkinson Disease Center and Movement Disorders Clinic at Baylor College of Medicine.
Book Release – Dystonia. World Federation of Neurology Seminars in Clinical Neurology, Volume 3 April 1, 2005: This volume is the third in a series developed under the auspices of the World Federation of Neurology to meet the needs of neurologists who must practice medicine without many of the advantages that are often taken for granted in the industrialized world.
Ailing, aged find inspiration in pope's endurance Feb. 26, 2005: For more than a quarter century, the world has looked on as the once vibrant and globe-trotting pope has aged, his speech slurring and step faltering with Parkinson's disease.
Breathing trouble could be tied to pneumonia Feb. 26, 2005: But in patients such as Pope John Paul II, who also suffers from Parkinson's disease, the problem could stem from something other than the flu.
Effectiveness of Parkinson's drug upheld Feb. 15, 2005: Levodopa or L-dopa – long an accepted treatment in Parkinson's disease – remains the gold standard, said an expert at Baylor College of Medicine (BCM).
Genetic mutation sheds light on Parkinson's origins Jan. 28, 2005: Neurologists have isolated a gene mutation responsible for both familial and sporadic forms of Parkinson's disease.
Botox suppresses involuntary tics Jan. 15, 2005: The cosmetic cure-all Botox may have found another market: sufferers of Tourette's syndrome.
Tourette Syndrome and Related Neurobehavioral Disorders (ADHD, OCD) Symposium Jan. 14, 2005
Botox may help people with movement disorders Jan. 11, 2005: The long-term effects of botulinum toxin type A (Botox) in patients with severe movement disorders confirm the safety of the toxin's use in controlled dosages, according to a recent study at Baylor College of Medicine in Houston.
Toxic treatment could turn tide on Tourette's Dec. 17, 2004: The cosmetic cure-all Botox may have found another market: sufferers of Tourette's syndrome.
2004 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2004: As in the past, the Thanksgiving season has offered me an opportunity to reflect on the accomplishments and goals of the Parkinson Disease Center and Movement Disorders Clinic at Baylor College of Medicine and to express my gratitude to my friends and colleagues for their continued support.
Huntington's disease gala to spotlight research progress Sept. 16, 2004: The Huntington's Disease Society of America will host a dinner and gala Sept. 22, benefiting local research efforts for a cure for the degenerative disease.
BCM team investigates early signs, treatments of Huntington's June 15, 2004: Identifying the first indicators of Huntington's disease could improve treatment options for the disorder, according to researchers at Baylor College of Medicine in Houston.
BCM team investigates early signs, treatments of Huntington's June 7, 2004: Identifying the first indicators of Huntington's Disease could improve treatment options for the disorder, according to researchers at Baylor College of Medicine in Houston.
2003 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2003: Each year I look forward to preparing this brief report of our clinical, research and educational activities because it gives me an opportunity to reflect on the accomplishments and goals of the Parkinson Disease Center and Movement Disorders Clinic at Baylor College of Medicine during the past year and to express my gratitude to my patients, friends and colleagues for their continued support.
Golf tournament to support Parkinson's disease research Sept. 23, 2003: Golf lovers can tee off for a good cause Oct. 20 at the Dr. Sol and Miriam Rogers Memorial Golf Tourney in Beaumont. All proceeds from the event will go to the Parkinson's Research Endowment Fund at Baylor College of Medicine in Houston.
Rare neurological disease brings couple closer together June 8, 2003: In August 2000, Joe was diagnosed with progressive supranuclear palsy, a neurological illness that attacks portions of the midbrain, or movement center, which controls balance and speech.
Michael J. Fox to attend Baylor Parkinson's fundraiser Feb. 28, 2003: Michael J. Fox will be the special guest at the Parkinson's Research Endowment Fund Dinner March 6.
2002 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2002: Each year during the season of Thanksgiving I take the opportunity to reflect on the accomplishments and goals of the Parkinson Disease Center and Movement Disorders Clinic at Baylor College of Medicine and to express my gratitude to my friends and colleagues for their continued support.
Research offers hope to patients with Parkinson's disease Oct. 10, 2002: New drugs and surgical procedures are already being tested in the laboratory - treatments that hold real promise for those who suffer from this disorder.
Botox used to treat eye disorder Sept. 19, 2002: Thirty years ago, blepharospasm -- a condition in which involuntary muscle contractions can cause the eyelid to close -- was misdiagnosed as dry eye, an allergy problem or nervous habit.
Retiring county commissioner says he still feels 'great' Aug. 23, 2002: Harris County Commissioner Jim Fonteno, affectionately called "the dean" of Commissioners Court by his colleagues, said Thursday he has been diagnosed with Parkinson's disease.
Pope's failing health plaguing latest tour of Americas July 23, 2002: The 82-year-old pontiff is showing the wear of time and Parkinson's disease as he embarks today on the 97th trip of his 24-year pontificate -- an 11-day tour to Canada, Guatemala and Mexico.
2001 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2001: As we approach this year's season of thanksgiving and reflect on the tragic events of the recent past I would like to provide this uplifting update on the activities of our Parkinson's Disease and Movement Disorders Center over the past year. I also want to express my deep gratitude for the positive year of accomplishment and share with you my vision for the future of the Center.
Drug testing on children aids in treatment July 22, 2001: In Houston, drug manufacturers can tap into an array of reputable facilities -- Baylor College of Medicine and The University of Texas MD Anderson Cancer Center, to name two -- where top-notch researchers are eager to try novel therapies that could help children like Abel, for whom conventional treatments have been unsuccessful.
Neurological disorders topic of session at school April 4, 2001: The Health and Safety Committee of the Parent Teacher Organization will present a full-day program, Monday on education and tolerance of children with attention deficit disorder, attention deficit hyperactivity disorder, obsessive-compulsive disorders and Tourette syndrome.

Joseph Jankovic, M.D.

2022

<2021